CME: Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea Medical Education on ReachMD

Overview
This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.
Target Audience
This activity has been designed to meet the educational needs of the interprofessional team, including sleep specialists who are Neurologists and Pulmonologists and General Neurologists, Nurses, and Pharmacists involved in the management of patients with obstructive sleep apnea (OSA).
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Utilize validated diagnostic tools when assessing residual EDS due to OSA
- Understand the burden, risk factors, and prevalence of EDS due to OSA
- Develop an evidence-based, comprehensive treatment plan for the management of EDS due to OSA
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Faculty Disclosure of Commercial Relationships
Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.

The following faculty have disclosed:

Atul Malhotra, MD, chair for this educational event, is a contracted researcher for NIH; and receives consulting fees from LivaNova, Jazz Pharmaceuticals, Zoll, and Eli Lilly.

Christina Finch, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.

Neomi Shah, MD, MPH, MS, faculty for this educational event, is a contracted researcher for NIH, AASM Foundation, and Itamar Medical; has ownership interest in Abbott; and receives consulting fees from Respicardia and Bresotec.
Planners and Managers Disclosure List
The following planners/reviewers/managers have disclosed:

Alison S. Kole, MD, MPH, FCCP, FAASM, planner for this educational event, has no relevant financial relationships with ineligible companies.

William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

Total CME, LLC. Planners and managers have no relevant commercial relationships to disclose.

All the relevant financial relationships for these individuals have been mitigated.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go, you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Acknowledgment
This activity is supported by an independent educational grant from Axsome Therapeutics.
Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.
Fee Statement
This activity is FREE to all participants.
Instructions for Completion
During the period 8/25/2023 through 8/25/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:
1. Read the learning objectives and faculty disclosures.
2. Answer a pre-program question.
3. View the program.
4. Complete the post-test with a score of 100%.
5. Complete activity evaluation.
6. Apply for credit and either bank your credits or print your certificate.
For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.
System Requirements
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Publication Dates
Release Date: 08/25/2023
Expiration Date: 08/25/2024